Home
News
Create
Screeners
Insights
Mercury Laboratories
800.
00
+20.00
(+2.56%)
Market Cap
₹96.00 Cr
PE Ratio
19.84
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.56%
1M
-0.64%
6M
-6.71%
1Y
-7.29%
5Y
+25.20%
View Company Insights
Latest news about Mercury Laboratories
Mercury Laboratories Q3FY26 Results: Net Profit Falls 16.4% to ₹99.75 Lakhs
Feb 11, 2026
Mercury Laboratories announced mixed Q3FY26 results with quarterly net profit declining 16.4% to ₹99.75 lakhs and revenue dropping 6.2% to ₹1,835.03 lakhs. However, nine-month performance showed remarkable recovery with 77.3% profit growth to ₹360.84 lakhs. The company faced an exceptional charge of ₹39.49 lakhs due to new labour code implementation affecting gratuity calculations.
Mercury Laboratories Postpones New Injectable Plant Commissioning to December 2026
Nov 12, 2025
Mercury Laboratories Reports 70% Surge in Q2 Net Profit, Revenue Up 4.8%
Nov 12, 2025
Mercury Laboratories Appoints Seema Salvi as Head of Injectable Production Department
Nov 04, 2025
Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO